IFNA6
Reaktivität: Human
WB, IF (cc), IF (p)
Wirt: Kaninchen
Polyclonal
Cy5
Applikationshinweise
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
Konservierungsmittel
ProClin
Vorsichtsmaßnahmen
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Haltbarkeit
12 months
Target
IFNA6
(Interferon, alpha 6 (IFNA6))
Andere Bezeichnung
IFNA6
Hintergrund
Interferon alpha-6, IFN-alpha-6, Interferon alpha-54, Interferon alpha-K, LeIF KIFNA6 (Interferon Alpha 6) is a Protein Coding gene. Diseases associated with IFNA6 include Extrinsic Cardiomyopathy. Among its related pathways are Response to elevated platelet cytosolic Ca2+ and PI3K-Akt signaling pathway. Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase.